80
Participants
Start Date
April 16, 2018
Primary Completion Date
July 30, 2021
Study Completion Date
August 2, 2021
ex-vivo drug response assay
drug sensitivity testing of primary patient derived cancer cells
University Hospital Heidelberg, Heidelberg
University Hospital Heidelberg
OTHER
German Cancer Research Center
OTHER